TLR1 and cancer: In our study, the older subjects (average age 74.5 years) remain healthy into old age, suggesting that the TLR1-mediated reduction in PMN function reported here, one of multiple deficiencies noted in immunosenescence [1], may be relevant to surviving other health complications, such as cancer or autoimmune diseases.